Starpharma Holdings Ltd

124 articles about Starpharma Holdings Ltd

• Starpharma Release: Enrolment Complete For Phase 3 VivaGel BV-R Program

  10/13/2016

• Starpharma Release: VivaGel Condom Receives Regulatory Approval In Canada

  9/13/2016

• Starpharma Initiates New DEP Drug Delivery Program With AstraZeneca PLC

  7/28/2016

• Starpharma Signs License For A VivaGel Condom In China

  7/21/2016

• Australia's Starpharma, Ansell To Supply Anti-Zika Condoms For Olympics

  5/16/2016

• Starpharma Release: VivaGel Active Against Zika Virus

  5/5/2016

• Starpharma Release: DEP Cabazitaxel Shows Complete And Sustained Tumour Regression In Breast Cancer Model

  4/4/2016

• Adama Licenses Starpharma 's Priostar Dendrimer Technology For The Development And Commercialization Of A Novel 2,4-D Product For The U.S. Market

  3/17/2016

• Starpharma Licences VivaGel BV To Aspen Pharmacare For ANZ

  3/4/2016

• Starpharma Interim Report And Half-Year Financial Results

  2/17/2016

• Starpharma Signs MOU For VivaGel Condom In China

  12/16/2015

• Starpharma Completes A $32 Million Placement - SPP To Follow

  12/9/2015

• Starpharma Release: Second DEP Candidate Selected By AstraZeneca PLC

  12/2/2015

• Starpharma 's Targeted DEP Outperforms Leading Treatments In Ovarian Cancer Model

  11/16/2015

• Starpharma Release: EU Marketing Approval Granted For VivaGel BV

  9/24/2015

• AstraZeneca PLC And Starpharma Ink Drug Delivery Deal Worth up to $450 Million

  9/8/2015

• Starpharma Holdings Ltd CEO Dr. Jackie Fairley To Be Interviewed Live On Iheart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's

  2/17/2015

• FDA Green Lights Starpharma Holdings Ltd's VivaGel Trial Design

  7/14/2014

• Rob Thomas Succeeds Retiring Starpharma Holdings Ltd Chairman Peter Bartels

  6/13/2014

• Starpharma Holdings Ltd's Clinical Trial Programs Accelerating

  6/5/2014